RecruitingNot ApplicableNCT06837506

Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy

Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy: A Randomized Trial


Sponsor

Ain Shams University

Enrollment

80 participants

Start Date

Feb 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the effectiveness and safety of ultrasound-guided rectus sheath block versus intrathecal morphine for postoperative analgesia in patients undergoing open total abdominal hysterectomy.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Age: 18 - 65 years old.
  • American Society of Anesthesiologists (ASA) physical status (I -II).
  • Patients undergoing open total abdominal hysterectomy.

Exclusion Criteria4

  • Hepatic, renal, or cardiac disease.
  • Any known allergy to local anesthetic.
  • Physical or mental conditions which may vague measuring postoperative pain following surgery.
  • History of chronic use of analgesic as nonsteroidal anti-inflammatory drugs (NSAIDs) or central nervous system (CNS) depressants as antiepileptic, and bleeding disorders.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRectus sheath block

Patients will receive rectus sheath block (20 ml bilaterally, bupivacaine 0.25%) after induction of general anesthesia.

DRUGIntrathecal morphine

Patients will receive 150 µg intrathecal morphine after induction of general anesthesia.


Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06837506


Related Trials